Associations of acetylcholinesterase inhibitor treatment with reduced mortality in Alzheimer's disease: a retrospective survival analysis
Author(s) -
Christoph Mueller,
Gayan Perera,
Richard D. Hayes,
Hitesh Shetty,
Robert Stewart
Publication year - 2017
Publication title -
age and ageing
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.014
H-Index - 143
eISSN - 1468-2834
pISSN - 0002-0729
DOI - 10.1093/ageing/afx098
Subject(s) - medicine , acetylcholinesterase , retrospective cohort study , disease , acetylcholinesterase inhibitor , alzheimer's disease , survival analysis , gerontology , oncology , biochemistry , chemistry , enzyme
dementia is increasingly recognised as life-limiting condition. Although the benefits of acetylcholinesterase inhibitors (AChEIs) on cognition and function are well established, their effect on survival is less clear.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom